Related Experiment Videos

Increased local complement levels upon intraperitoneal injection of mice with Listeria monocytogenes and regulation

Infection and Immunity
|September 1, 1985
PubMed

Insights

Mouse complement activity varies significantly between strains. Heat-inactivated Listeria monocytogenes boosts local complement, an effect modulated by dextran sulfate, not heparin, impacting vaccine adjuvant potential.

Area of Science:

  • Immunology
  • Microbiology
  • Complement System Research

Background:

  • The alternative complement pathway plays a crucial role in innate immunity.
  • Understanding complement activation by pathogens like Listeria monocytogenes is vital for vaccine development.
  • Variability in complement activity can influence immune responses and vaccine efficacy.

Purpose of the Study:

  • To quantify alternative complement pathway activity in mouse peritoneal fluid.
  • To investigate the impact of Listeria monocytogenes on local complement activity.
  • To evaluate the adjuvant potential of dextran sulfate and heparin in a heat-inactivated Listeria vaccine model.

Main Methods:

  • A microtiter assay using rabbit erythrocytes and cobra venom factor was employed to measure complement activity.
  • Complement activity was assessed in five different mouse strains.
  • The effect of intraperitoneal injection of heat-inactivated Listeria monocytogenes, with or without dextran sulfate or heparin, was evaluated.

Main Results:

  • Significant intra- and interstrain variations in alternative complement pathway activity were observed (up to 64%).
  • No complement activity was detected in C5-deficient mice, confirming the role of the complement system.
  • Heat-inactivated Listeria monocytogenes induced a 250% increase in local complement activity within 30 minutes, which was reversed by dextran sulfate but not heparin.

Conclusions:

  • Mouse alternative complement pathway activity exhibits considerable strain-dependent variation.
  • Listeria monocytogenes effectively activates the alternative complement pathway in vivo.
  • Dextran sulfate, but not heparin, acts as an adjuvant by modulating complement activity, suggesting its potential utility in vaccine formulations.

Related Concept Videos